NASDAQ, ATRC - Atricure Inc

We are a medical device company and a leader in developing, manufacturing and  selling innovative cardiac surgical ablation systems designed to create precise  lesions, or scars, in cardiac, or heart, tissue. Medical journals have described  the adoption by leading cardiothoracic surgeons of our Isolator ? bipolar  ablation clamp system as a treatment alternative during open-heart surgical  procedures to create lesions in cardiac tissue to block the abnormal electrical  impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of  the upper chambers of the heart. Additionally, leading cardiothoracic surgeons,  treatment guidelines as published by the Heart Rhythm Society and publications  in medical journals have described our Isolator ? system as a standard treatment  alternative for AF patients who may be candidates for sole-therapy minimally  invasive surgical procedures.  ...

Sector:	Health Care
Industry:	Medical/Dental Instruments
P/E Ratio:	N/A
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	3.4574
PtS:	4.44
EBITDA:	N/A
Shares:	49.5M
Market Cap:	1.749B
52wk range:	20.20 - 43.11

216.73.216.229
United States